AstraZeneca is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Headquartered in Cambridge, UK, AstraZeneca’s innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. In Finland, AstraZeneca employs close to 100 people.
Addressing the challenges facing sustainable healthcare requires broad collaboration. AstraZeneca is committed to building partnerships that drive innovation, as exemplified by BioVentureHub in Gothenburg, Sweden. This open innovation platform brings together biotechnology, medtech, and digital health companies alongside AstraZeneca scientists, enabling the sharing of expertise, infrastructure, and insights to accelerate healthcare innovation.
AstraZeneca’s membership in CleverHealth Network is a natural extension of this commitment to advancing the future of healthcare through partnership and innovation.
Read more about AstraZeneca at www.astrazeneca.com.
